These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Non-subtype-selective opioid receptor antagonism in treatment of levodopa-induced motor complications in Parkinson's disease. Fox S; Silverdale M; Kellett M; Davies R; Steiger M; Fletcher N; Crossman A; Brotchie J Mov Disord; 2004 May; 19(5):554-60. PubMed ID: 15133820 [TBL] [Abstract][Full Text] [Related]
12. Effects of methylphenidate on response to oral levodopa: a double-blind clinical trial. Nutt JG; Carter JH; Carlson NE Arch Neurol; 2007 Mar; 64(3):319-23. PubMed ID: 17353373 [TBL] [Abstract][Full Text] [Related]
13. Effect of simvastatin on L-DOPA-induced abnormal involuntary movements of hemiparkinsonian rats. Wang T; Cao X; Zhang T; Shi Q; Chen Z; Tang B Neurol Sci; 2015 Aug; 36(8):1397-402. PubMed ID: 25787808 [TBL] [Abstract][Full Text] [Related]
14. Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia. Muñoz A; Li Q; Gardoni F; Marcello E; Qin C; Carlsson T; Kirik D; Di Luca M; Björklund A; Bezard E; Carta M Brain; 2008 Dec; 131(Pt 12):3380-94. PubMed ID: 18952677 [TBL] [Abstract][Full Text] [Related]
15. Onset of dyskinesia with adjunct ropinirole prolonged-release or additional levodopa in early Parkinson's disease. Watts RL; Lyons KE; Pahwa R; Sethi K; Stern M; Hauser RA; Olanow W; Gray AM; Adams B; Earl NL; Mov Disord; 2010 May; 25(7):858-66. PubMed ID: 20461803 [TBL] [Abstract][Full Text] [Related]
17. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses. Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222 [TBL] [Abstract][Full Text] [Related]
18. A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced Dyskinesia. Trenkwalder C; Berg D; Rascol O; Eggert K; Ceballos-Baumann A; Corvol JC; Storch A; Zhang L; Azulay JP; Broussolle E; Defebvre L; Geny C; Gostkowski M; Stocchi F; Tranchant C; Derkinderen P; Durif F; Espay AJ; Feigin A; Houeto JL; Schwarz J; Di Paolo T; Feuerbach D; Hockey HU; Jaeger J; Jakab A; Johns D; Linazasoro G; Maruff P; Rozenberg I; Sovago J; Weiss M; Gomez-Mancilla B Mov Disord; 2016 Jul; 31(7):1049-54. PubMed ID: 26990766 [TBL] [Abstract][Full Text] [Related]
19. Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease. Borgohain R; Szasz J; Stanzione P; Meshram C; Bhatt MH; Chirilineau D; Stocchi F; Lucini V; Giuliani R; Forrest E; Rice P; Anand R; Mov Disord; 2014 Sep; 29(10):1273-80. PubMed ID: 25044402 [TBL] [Abstract][Full Text] [Related]
20. Study of istradefylline in patients with Parkinson's disease on levodopa with motor fluctuations. Hauser RA; Shulman LM; Trugman JM; Roberts JW; Mori A; Ballerini R; Sussman NM; Mov Disord; 2008 Nov; 23(15):2177-85. PubMed ID: 18831530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]